Frank Gerdsen

Summary

Publications

  1. ncbi Platelet activation markers in patients with venous thromboembolism without predisposing factors
    Frank Gerdsen
    Vascular Centre Berlin, Department of Internal Medicine, Evangelisches Krankenhaus Konigin Elisabeth Herzberge, Berlin, Germany
    Pathophysiol Haemost Thromb 34:1-5. 2005
  2. ncbi A prospective analysis of heparin-platelet factor 4 antibodies in pregnant women treated with the low-molecular-weight heparin, dalteparin
    Frank Gerdsen
    DRK Kliniken Berlin Köpenick, Department of Internal Medicine, Vascular Center Berlin Köpenick, Germany
    Blood Coagul Fibrinolysis 19:477-81. 2008
  3. ncbi Risk factors and long-term follow-up of patients with the immune type of heparin-induced thrombocytopenia
    Edelgard Lindhoff-Last
    Department of Internal Medicine, Division of Angiology, University Hospital Frankfurt, Germany
    Clin Appl Thromb Hemost 8:347-52. 2002

Detail Information

Publications3

  1. ncbi Platelet activation markers in patients with venous thromboembolism without predisposing factors
    Frank Gerdsen
    Vascular Centre Berlin, Department of Internal Medicine, Evangelisches Krankenhaus Konigin Elisabeth Herzberge, Berlin, Germany
    Pathophysiol Haemost Thromb 34:1-5. 2005
    ..In conclusion, the expression of CD62 and CD63 of resting and in vitro activated platelets could not be established as a risk factor for spontaneous venous thromboembolism...
  2. ncbi A prospective analysis of heparin-platelet factor 4 antibodies in pregnant women treated with the low-molecular-weight heparin, dalteparin
    Frank Gerdsen
    DRK Kliniken Berlin Köpenick, Department of Internal Medicine, Vascular Center Berlin Köpenick, Germany
    Blood Coagul Fibrinolysis 19:477-81. 2008
    ..These findings suggest that long-term thromboprophylaxis with low-molecular-weight heparin is associated with a low rate of HPF4-As seroconversion in pregnancy...
  3. ncbi Risk factors and long-term follow-up of patients with the immune type of heparin-induced thrombocytopenia
    Edelgard Lindhoff-Last
    Department of Internal Medicine, Division of Angiology, University Hospital Frankfurt, Germany
    Clin Appl Thromb Hemost 8:347-52. 2002
    ..Increased factor VIII activity was frequently observed in patients in whom HIT developed. Thromboembolic complications within the first months after onset of HIT occurred often...